Unannounced FDA Inspections at Gummy Facilities: What Investigators Look for First

Why Unannounced Inspections Hit Gummy Facilities Differently

Most gummy supplement manufacturers understand that FDA inspections are a possibility. Fewer are prepared for the specific reality of an unannounced inspection — one where an investigator from the Office of Regulatory Affairs arrives with credentials, a Form 482 Notice of Inspection, and no prior scheduling. Under 21 CFR Part 111, dietary supplement facilities are subject to inspection at any reasonable time, and the FDA does not owe you advance notice. That gap between knowing inspections can happen and being ready for one on a random Tuesday morning is where most compliance failures occur.

Gummy manufacturing compounds this challenge because the process is continuous, temperature-sensitive, and highly dependent on in-process controls that change hour by hour. A capsule or tablet facility can often pause production and gather records without dramatically altering what the investigator observes. A gummy line running a gelatin cook at 240°F or a mogul depositing system mid-batch cannot simply stop. The investigator sees your operation exactly as it runs — personnel behavior, in-process documentation habits, equipment condition, and environmental controls all become evidence in real time.

Understanding what FDA investigators look for first — before they move into records review — is the foundation of credible inspection readiness. This article walks through those priorities so your QA team and production supervisors know exactly where to focus.

The First Fifteen Minutes: What Investigators Observe Before Asking for a Single Record

Experienced FDA investigators are trained to observe before they request. From the moment they enter your facility, they are building a picture of your quality culture. This observation phase typically covers your production floor, personnel practices, and the physical state of your equipment — all before your QA manager has printed a single batch record.

Personnel and Hygiene Controls

Investigators watch how employees move through your facility. Are gowning procedures being followed consistently, or only when a supervisor is present? Do technicians handling open gummy mass wear appropriate gloves and hair restraints? Are personnel re-gowning after breaks, or skipping steps because production pressure is high? Under 21 CFR Part 111 Subpart B, personnel hygiene and training requirements are among the most frequently cited observation categories — and violations are visible within seconds of entering a production area.

For gummy facilities specifically, pay attention to how staff handle the cooking and depositing stages. Open kettles, mogul trays, and coating drums represent allergen and contamination exposure points. If your SOPs require glove changes between flavor runs or before contact with open product, investigators will notice immediately whether that practice is actually happening.

Equipment Condition and Sanitation Status

The investigator will scan your depositing equipment, starch mogul systems, coating pans, and cooling tunnels for visible residue, standing water, or signs of inadequate cleaning. Gelatin residue left in a kettle or depositor nozzle is not just a quality problem — it is a microbial harborage point and a direct 21 CFR Part 111 violation if your cleaning verification records do not match the physical state of the equipment. Investigators are specifically trained to look for discrepancies between what records say was cleaned and what equipment actually looks like.

Water activity is a gummy-specific control point that investigators increasingly understand. If your facility lacks calibrated water activity meters or cannot demonstrate how finished gummy batches are released against a validated water activity specification, that gap will be noted. An aw above 0.60 in a finished gummy is a microbial risk, and an investigator who understands this will ask for your in-process and finished product testing data immediately after observing production conditions.

Environmental and Storage Conditions

Gummy supplements are hygroscopic. Finished product stored in conditions that exceed validated temperature and humidity ranges will absorb moisture, lose form, and potentially undergo bloom degradation — even after passing release testing. Investigators look at warehouse conditions, packaging staging areas, and quarantine zones to determine whether your environmental controls are real or theoretical. If your SOPs specify 65°F and 40% relative humidity for finished gummy storage but your warehouse thermohygrometer reads 75°F and 58% RH, you have a documentation-versus-reality problem that no batch record can fix in the moment.

Records and Documentation: What Gets Requested in the First Hour

Once the floor observation is complete, the investigator will request records. This is where gummy manufacturers who rely on informal systems, incomplete batch records, or inconsistent SOP versioning face the most serious risk. The documentation requests are predictable — which means there is no reason to be caught unprepared.

Master Manufacturing Records and Batch Production Records

Under 21 CFR Part 111.205, every batch must be manufactured and documented in accordance with a written Master Manufacturing Record (MMR). The investigator will request your MMR alongside the corresponding Batch Production Records (BPRs) for recently produced lots and compare them line by line. Common failures in gummy facilities include:

• In-process parameters recorded as ranges rather than actual values (e.g., "cook temp OK" instead of "242°F")
• Missing technician initials for critical steps such as gelatin hydration time or bloom strength verification
• Corrections made with correction fluid rather than single-line strikethrough with initials and date
• Yield reconciliation calculations absent or incomplete for depositing and drying stages
• Bloom strength test results not linked to the specific gelatin lot used in the batch

Each of these issues is individually citable under 21 CFR Part 111. Collectively, they suggest a quality system where documentation is treated as paperwork rather than evidence — and investigators document that distinction explicitly in their observations.

Laboratory Controls and In-Process Testing Records

Investigators will ask for your laboratory control records, including in-process moisture testing, finished product water activity results, potency testing for active ingredients, and identity verification for incoming raw materials. For gummy manufacturers, the identity testing requirement under 21 CFR Part 111.75 is a persistent observation trigger. Testing the COA provided by your gelatin or pectin supplier is not identity testing. You must conduct or commission testing that confirms the identity of each raw material lot — and that testing must be documented with the specific lot number and a clear pass/fail determination.

If you use a third-party laboratory for finished product testing, investigators will review whether your laboratory is qualified, whether specifications were established before testing began, and whether any out-of-specification results triggered a formal investigation. A single OOS result that was resolved with a notation of "retest — passed" without a documented investigation is a significant finding under 21 CFR Part 111.95.

CAPA and Complaint Records

Your CAPA system tells the investigator whether your quality program is reactive or proactive. They will ask for recent CAPA records, look at whether root cause analysis goes beyond operator error as an explanation, and verify that corrective actions were implemented and effectiveness-verified on schedule. For gummy-specific issues — sticking, bloom failure, moisture excursions, short fill weights — the CAPA record should reflect an understanding of the underlying chemistry, not just a surface-level fix.

The Most Common Gummy-Specific Observations During FDA Inspections

Based on FDA enforcement data, warning letters, and Form 483 observation trends, gummy supplement facilities are most frequently cited for a predictable cluster of issues. Understanding these patterns allows your team to conduct targeted self-assessments before an investigator arrives.

Process Validation Gaps

Gummy manufacturing involves multiple critical process parameters (CPPs) — cook temperature, hold time, depositing temperature, starch moisture content, cooling tunnel time, and coating application rate — that directly affect finished product quality and safety. Many facilities have never formally validated these parameters against finished product specifications. Without process validation data, you cannot demonstrate that your process consistently produces a product that meets all established specifications, which is a foundational requirement under 21 CFR Part 111.68.

Inadequate Supplier Qualification

Relying solely on a supplier's COA without conducting incoming identity testing is one of the most cited observations across the gummy category. Gelatin suppliers, pectin suppliers, active ingredient vendors, and color and flavor suppliers all require qualification — including evaluation of their quality systems, not just review of their documentation. Investigators will ask for your Approved Supplier List, your qualification criteria, and evidence of how recently each critical supplier was re-evaluated.

SOP Gaps and Training Documentation

SOPs that were written during initial facility setup and never updated to reflect equipment changes, formulation changes, or personnel changes are a consistent finding. Investigators cross-reference SOP version dates with training records to determine whether personnel were trained on current procedures. If your depositor was replaced eighteen months ago and your cleaning SOP still references the original equipment model, that discrepancy will be noted.

Environmental Monitoring Absence

While gummy supplements are not sterile products, facilities without any environmental monitoring program — surface swabbing, air sampling for particulates, pest control records — signal a quality program that has not thought through contamination risk holistically. Investigators increasingly expect to see documented environmental monitoring results, particularly in facilities where product is exposed during cooking, depositing, or drying stages.

Building Inspection Readiness as an Operational Standard, Not a Pre-Audit Sprint

The most inspection-ready gummy facilities are not the ones that scramble for two weeks before a third-party audit. They are the ones that have made compliance an operational standard — where batch records are completed accurately in real time, where SOPs are reviewed on a defined schedule, where CAPA investigations are closed on time, and where QA is involved in production decisions rather than reviewing paperwork after the fact.

Practical steps that move a gummy facility from reactive to genuinely inspection-ready include:

1. Conduct quarterly internal mock inspections using FDA's CGMP inspection approach — walk the floor unannounced, pull random batch records, and review documentation against current SOPs before an investigator does.
2. Establish a document control system that prevents superseded SOPs from circulating on the production floor. Every operator should have access to current procedures and be able to locate them without asking a supervisor.
3. Standardize batch record completion training so all production staff understand that entries must reflect actual values, actual times, and actual conditions — not approximations or retroactive reconstructions.
4. Maintain a current inspection readiness binder that includes your most recent MMRs, the last three months of BPRs for high-volume SKUs, current supplier qualification files, and your open and closed CAPA log. This binder should be accessible to your QA manager within five minutes of an investigator arriving.
5. Review FDA warning letters issued to other gummy and supplement manufacturers on a quarterly basis. These publicly available documents reveal exactly what investigators are observing and how FDA characterizes violations — and they are the best free intelligence available on where your program may have blind spots.

FDA inspection readiness is not a certification you earn once and hold indefinitely. For gummy manufacturers, it is a daily practice built on accurate documentation, validated controls, qualified suppliers, and a quality team that understands the unique process demands of gelatin and pectin-based products. The facilities that navigate unannounced inspections successfully are not lucky — they are ready before the investigator knocks.